Search research articles
Contact Us
Filters
Showing results (211-220 of 217) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 217 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 1, 1977
Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals
B M Gallagher, A Ansari, H Atkins, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 1983
Quantitative autoradiography with radiopharmaceuticals, Part 2: Applications in radiopharmaceutical research: concise communication
P Som, Y Yonekura, Z H Oster, et al.
AJNR. American Journal of Neuroradiology
|
May 1, 1983
Positron emission tomographic studies of aging and Alzheimer disease
M J de Leon, S H Ferris, A E George, et al.
Neurology
|
December 1, 1982
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography
G Di Chiro, R L DeLaPaz, R A Brooks, et al.
Radiology
|
September 1, 1982
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain
N J Patronas, G Di Chiro, R A Brooks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 1980
A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection
P Som, H L Atkins, D Bandoypadhyay, et al.
International Journal of Nuclear Medicine and Biology
|
March 1, 1978
Distribution of 18F-5-fluorouracil in tumor-bearing mice and rats
J Shani, W Wolf, T Schlesinger, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 217) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 217 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 1, 1977
Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals
B M Gallagher, A Ansari, H Atkins, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 1983
Quantitative autoradiography with radiopharmaceuticals, Part 2: Applications in radiopharmaceutical research: concise communication
P Som, Y Yonekura, Z H Oster, et al.
AJNR. American Journal of Neuroradiology
|
May 1, 1983
Positron emission tomographic studies of aging and Alzheimer disease
M J de Leon, S H Ferris, A E George, et al.
Neurology
|
December 1, 1982
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography
G Di Chiro, R L DeLaPaz, R A Brooks, et al.
Radiology
|
September 1, 1982
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain
N J Patronas, G Di Chiro, R A Brooks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 1980
A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection
P Som, H L Atkins, D Bandoypadhyay, et al.
International Journal of Nuclear Medicine and Biology
|
March 1, 1978
Distribution of 18F-5-fluorouracil in tumor-bearing mice and rats
J Shani, W Wolf, T Schlesinger, et al.
Page
of 22